申请人:REYNOLDS MAX
公开号:WO2009141645A1
公开(公告)日:2009-11-26
The present invention relates to the use of a non-monoterpenoid compound derived from Melaleuca plant for the treatment or prophylaxis of cancer. In particular, the present invention relates to a composition derived from Melaleuca Alternifolia comprising enhanced levels of sesquiterpenes for the treatment or prophylaxis of cancer.